Skip to main content

Epoetin Alfa Injection Shortage

Last Updated: May 3, 2024
Status: Current

Products Affected - Description
    • Retacrit solution for injection, Pfizer, 2,000 unit/mL, 1 mL single dose vial, 10 count, NDC 00069-1305-10
    • Retacrit solution for injection, Pfizer, 20,000 unit/2 mL, 1 mL multiple dose vial, 10 count, NDC 00069-1318-10
    • Retacrit solution for injection, Pfizer, 20,000 unit/mL, 1 mL multiple dose vial, 10 count, NDC 00069-1311-10
    • Retacrit solution for injection, Pfizer, 3,000 unit/mL, 1 mL single dose vial, 10 count, NDC 00069-1306-10
    • Retacrit solution for injection, Pfizer, 4,000 unit/mL, 1 mL single dose vial, 10 count, NDC 00069-1307-10
Reason for the Shortage
    • Amgen has Epogen available.
    • Janssen has Procrit available.
    • Pfizer states the reason for the shortage is manufacturing delay.
Available Products
    • Epogen solution for injection, Amgen, 10,000 unit/mL, 1 mL single dose vial, 10 count, NDC 55513-0144-10
    • Epogen solution for injection, Amgen, 2,000 unit/mL, 1 mL single dose vial, 10 count, NDC 55513-0126-10
    • Epogen solution for injection, Amgen, 20,000 unit/2 mL, 2 mL multiple dose vial, 10 count, NDC 55513-0283-10
    • Epogen solution for injection, Amgen, 20,000 unit/mL, 1 mL multiple dose vial, 10 count, NDC 55513-0478-10
    • Epogen solution for injection, Amgen, 3,000 unit/mL, 1 mL single dose vial, 10 count, NDC 55513-0267-10
    • Epogen solution for injection, Amgen, 4,000 unit/mL, 1 mL single dose vial, 10 count, NDC 55513-0148-10
    • Procrit solution for injection, Janssen, 10,000 unit/mL, 1 mL single dose vial, 6 count, NDC 59676-0310-01
    • Procrit solution for injection, Janssen, 10,000 unit/mL, 1 mL single dose vial, 25 count, NDC 59676-0310-02
    • Procrit solution for injection, Janssen, 2,000 unit/mL, 1 mL single dose vial, 6 count, NDC 59676-0302-01
    • Procrit solution for injection, Janssen, 20,000 unit/2 mL, 2 mL multiple dose vial, 4 count, NDC 59676-0312-04
    • Procrit solution for injection, Janssen, 20,000 unit/mL, 1 mL multiple dose vial, 4 count, NDC 59676-0320-04
    • Procrit solution for injection, Janssen, 3,000 unit/mL, 1 mL single dose vial, 6 count, NDC 59676-0303-01
    • Procrit solution for injection, Janssen, 4,000 unit/mL, 1 mL single dose vial, 6 count, NDC 59676-0304-01
    • Procrit solution for injection, Janssen, 40,000 unit/mL, 1 mL single dose vial, 4 count, NDC 59676-0340-01
    • Retacrit solution for injection, Pfizer, 10,000 unit/mL, 1 mL single dose vial, 10 count, NDC 00069-1308-10
    • Retacrit solution for injection, Pfizer, 40,000 unit/mL, 1 mL single dose vial, 4 count, NDC 00069-1309-04

Estimated Resupply Dates

    • Pfizer has Retacrit 2,000 units/mL 1 mL vials, 3,000 units/mL 1 mL vials, 4,000 units/mL 1 mL vial, and 20,000 unit/mL 1 mL vials on back order and the company estimates a release date of June 2024. The 20,000 units/2 mL 1 mL vials are on back order and the company cannot estimate a release date.

Updated

Updated May 3, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 27, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.